| Nutherapy | |
|
550 Se 6th Ave # 200 Delray Beach FL 33483-5306 | |
| (954) 686-6577 | |
| (954) 245-0548 |
| Full Name | Nutherapy |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 550 Se 6th Ave # 200, Delray Beach, Florida |
| Authorized Official Name and Position | Romil Benoit (OFFICE MANAGER) |
| Authorized Official Contact | 5615736528 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Nutherapy 550 Se 6th Ave Ste 200 Delray Beach FL 33483-5306 Ph: (754) 206-7025 | Nutherapy 550 Se 6th Ave # 200 Delray Beach FL 33483-5306 Ph: (954) 686-6577 |
| NPI Number | 1164090924 |
|---|---|
| Provider Enumeration Date | 06/16/2021 |
| Last Update Date | 07/10/2023 |
| Certification Date | 07/10/2023 |
| Medicare PECOS PAC ID | 8628442142 |
|---|---|
| Medicare Enrollment ID | O20230324001425 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
Afatinib has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).
More than 30 years into the AIDS epidemic, a combination of safe-sex education and a new generation of pharmaceuticals has left many Americans convinced that HIV/AIDS is a problem that has been, if not solved, at least addressed. But that's certainly not true in the American South, which accounts for nearly 50% of all new HIV infections in the United States.
Ocular trauma causing open globe injury, or a breach in the wall of the eye, remains an important cause of vision loss, with more than 200,000 open globe injuries occurring worldwide each year. In many cases, retinal detachment follows the traumatic injury, causing significant vision loss or blindness.
Nightmares are extremely dysphoric dreams, which are prevalent and associated with psychological strain. This study investigated (a) the efficacy of an internet-based imagery rehearsal therapy (IRT), (b) the role of imagery rescription, and (c) the role of guidance during internet-based IRT.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164090924 | NPI | - | NPPES |
| 111825200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Primary |
| Provider Name | Jean-baptiste R Jourdan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1588711683 PECOS PAC ID: 3476714734 Enrollment ID: I20120412000522 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
Afatinib has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).
More than 30 years into the AIDS epidemic, a combination of safe-sex education and a new generation of pharmaceuticals has left many Americans convinced that HIV/AIDS is a problem that has been, if not solved, at least addressed. But that's certainly not true in the American South, which accounts for nearly 50% of all new HIV infections in the United States.
Ocular trauma causing open globe injury, or a breach in the wall of the eye, remains an important cause of vision loss, with more than 200,000 open globe injuries occurring worldwide each year. In many cases, retinal detachment follows the traumatic injury, causing significant vision loss or blindness.
Nightmares are extremely dysphoric dreams, which are prevalent and associated with psychological strain. This study investigated (a) the efficacy of an internet-based imagery rehearsal therapy (IRT), (b) the role of imagery rescription, and (c) the role of guidance during internet-based IRT.
› Verified 6 days ago
| Provider Name | Murfy Morantus |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174030936 PECOS PAC ID: 6709141013 Enrollment ID: I20230524000235 |
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
Afatinib has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).
More than 30 years into the AIDS epidemic, a combination of safe-sex education and a new generation of pharmaceuticals has left many Americans convinced that HIV/AIDS is a problem that has been, if not solved, at least addressed. But that's certainly not true in the American South, which accounts for nearly 50% of all new HIV infections in the United States.
Ocular trauma causing open globe injury, or a breach in the wall of the eye, remains an important cause of vision loss, with more than 200,000 open globe injuries occurring worldwide each year. In many cases, retinal detachment follows the traumatic injury, causing significant vision loss or blindness.
Nightmares are extremely dysphoric dreams, which are prevalent and associated with psychological strain. This study investigated (a) the efficacy of an internet-based imagery rehearsal therapy (IRT), (b) the role of imagery rescription, and (c) the role of guidance during internet-based IRT.
› Verified 6 days ago
News Archive
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
Afatinib has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).
More than 30 years into the AIDS epidemic, a combination of safe-sex education and a new generation of pharmaceuticals has left many Americans convinced that HIV/AIDS is a problem that has been, if not solved, at least addressed. But that's certainly not true in the American South, which accounts for nearly 50% of all new HIV infections in the United States.
Ocular trauma causing open globe injury, or a breach in the wall of the eye, remains an important cause of vision loss, with more than 200,000 open globe injuries occurring worldwide each year. In many cases, retinal detachment follows the traumatic injury, causing significant vision loss or blindness.
Nightmares are extremely dysphoric dreams, which are prevalent and associated with psychological strain. This study investigated (a) the efficacy of an internet-based imagery rehearsal therapy (IRT), (b) the role of imagery rescription, and (c) the role of guidance during internet-based IRT.
› Verified 6 days ago
Intervention Strategies, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 297 Ne 6th Ave, Delray Beach, FL 33483 Phone: 561-243-0407 Fax: 561-243-0030 | |
Jacqueline B Pevny Md Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2040 Alta Meadows Ln, Suite 1601, Delray Beach, FL 33444 Phone: 561-272-4888 | |
Carl A Salvati M D P A Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13455 Military Trl, Suite A, Delray Beach, FL 33484 Phone: 561-495-4644 Fax: 561-495-5191 | |
U Turn Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 206 Sw 13th Ave, Delray Beach, FL 33444 Phone: 954-746-8232 Fax: 954-746-8981 | |
Holistic Home & Health, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15200 Jog Rd, 303, Delray Beach, FL 33446 Phone: 828-237-1238 | |
Boca Palms Medical Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Congress Park Dr, Suite 100, Delray Beach, FL 33445 Phone: 561-361-6608 Fax: 561-361-9857 | |
Brian Gong Psychotherapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 Linton Blvd, Suite 200-a, Delray Beach, FL 33444 Phone: 561-501-1008 Fax: 561-431-2608 |